Empagliflozin in Patients With Cirrhosis and Ascites

NCT05726032 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Cirrhosis
Liver Failure

Interventions

DRUG: Empagliflozin 10 MG
DRUG: Matching Placebo

Sponsor

Yale University

Collaborators

[object Object]